(Q38440905)
Statements
1 reference
Phase II clinical trial of CD34+ cell therapy to explore endpoint selection and timing in patients with critical limb ischemia (English)
1 reference
Takayuki Asahara
Yasuyuki Fujita
Makoto Kinoshita
Yutaka Furukawa
Tohru Nagano
Hisako Hashimoto
Yasuhiko Hirami
Yasuo Kurimoto
Kyosuke Arakawa
Kazuo Yamazaki
Yukikatsu Okada
Nobuyuki Katakami
Emiko Uno
Yoshihiro Matsubara
Masanori Fukushima
Adel Nada
Douglas W Losordo
21 November 2013
1 reference